Overexpression of E2F6 mRNA was found to be associated with favourable OS of all GC patients, HR = 0.77 (0.65–0.92), P=0.0028 (Figure 6A) and mixed-type GC, HR = 0.33 (0.1–1.05), P=0.05 (Figure 6D). Here, E2F6 is linked to gastric cancer.